Narwhal Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,583
Closed -$801K 174
2023
Q3
$801K Sell
1,583
-2,499
-61% -$1.33M 0.1% 110
2023
Q2
$2.13M Buy
4,082
+2,106
+107% +$1.14M 0.25% 75
2023
Q1
$1.14M Sell
1,976
-204
-9% -$115K 0.14% 101
2022
Q4
$1.2M Sell
2,180
-774
-26% -$410K 0.16% 98
2022
Q3
$1.5M Buy
2,954
+798
+37% +$447K 0.22% 82
2022
Q2
$1.17M Sell
2,156
-933
-30% -$514K 0.16% 87
2022
Q1
$1.82M Buy
3,089
+2,075
+205% +$1.19M 0.21% 76
2021
Q4
$677K Buy
+1,014
New +$633K 0.08% 103

Other funds holding TMO

Narwhal Capital Management's TMO Position: Q4 2023 in Review

Narwhal Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 1,583 shares — an estimated $801K sold.

Narwhal Capital Management first reported a position in TMO in Q4 2021 and held it in 8 quarters. The position peaked at $2.13M in Q2 2023. 2,487 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

  • Narwhal Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
  • Narwhal Capital Management sold 1,583 Thermo Fisher Scientific shares in Q4 2023, an estimated $801K.
  • Narwhal Capital Management first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 8 quarters.
  • Narwhal Capital Management's Thermo Fisher Scientific position peaked at $2.13M in Q2 2023.
  • 2,487 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Narwhal Capital Management's 13F filing for Q4 2023, filed 25 Jan 2024.